The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome. [electronic resource]
Producer: 20120109Description: 4957-62 p. digitalISSN:- 1528-0020
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-HIV Agents -- administration & dosage
- Benzylamines
- Blood Cell Count
- Cyclams
- Dose-Response Relationship, Drug
- Female
- Heterocyclic Compounds -- administration & dosage
- Humans
- Immunologic Deficiency Syndromes -- blood
- Leukocytes -- drug effects
- Lymphopenia -- complications
- Male
- Middle Aged
- Primary Immunodeficiency Diseases
- Receptors, CXCR4 -- antagonists & inhibitors
- Treatment Outcome
- Warts -- blood
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.